You are here

Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd.
Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
CGN
CSE Index: 
Currency: 

Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.

You are here

Cognetivity Neurosciences Ltd. (CGN)

SEDAR Information

Company Info

Address
138 Holborn
London
UK
EC1N 2SW
United Kingdom
Phone
‭+44 7980 295361‬
Email
Tom.sawyer@cantab.net
Website
http://www.cognetivity.com
Listing date
Monday, March 19, 2018
Transfer Agent
TSX Trust Company

Capitalization

Issued & Outstanding: 
89556611
Reserved for Issuance: 
18286051

Bulletins

06/06/2024

2024-0603 - Suspensions - CGN, FDM.X, ICS, MINA, TONY, UGH

le 6 juin/June 2024

Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.